Artal Group’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,000,000
| Closed | -$7.77M | – | 94 |
|
|
2023
Q3 | $7.77M | Hold |
1,000,000
| – | – | 0.33% | 48 |
|
|
2023
Q2 | $9.68M | Hold |
1,000,000
| – | – | 0.3% | 50 |
|
|
2023
Q1 | $11M | Hold |
1,000,000
| – | – | 0.65% | 38 |
|
|
2022
Q4 | $4.32M | Hold |
1,000,000
| – | – | 0.24% | 63 |
|
|
2022
Q3 | $7.52M | Hold |
1,000,000
| – | – | 0.32% | 48 |
|
|
2022
Q2 | $10.1M | Hold |
1,000,000
| – | – | 0.54% | 34 |
|
|
2022
Q1 | $12.4M | Hold |
1,000,000
| – | – | 0.52% | 42 |
|
|
2021
Q4 | $22.9M | Hold |
1,000,000
| – | – | 0.62% | 40 |
|
|
2021
Q3 | $22.1M | Hold |
1,000,000
| – | – | 0.5% | 47 |
|
|
2021
Q2 | $13M | Hold |
1,000,000
| – | – | 0.26% | 72 |
|
|
2021
Q1 | $13M | Hold |
1,000,000
| – | – | 0.23% | 75 |
|
|
2020
Q4 | $13.8M | Hold |
1,000,000
| – | – | 0.3% | 71 |
|
|
2020
Q3 | $14.7M | Buy |
1,000,000
+100,000
| +11% | +$1.47M | 0.36% | 51 |
|
|
2020
Q2 | $14.6M | Buy |
900,000
+150,000
| +20% | +$2.44M | 0.41% | 45 |
|
|
2020
Q1 | $10.9M | Buy |
+750,000
| New | +$10.9M | 0.46% | 38 |
|